Evaluation of Continuous Symptom Treatment of ADHD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study is to test the hypothesis that atomoxetine administered orally, once a day, at doses up to 1.4 mg/kg/day for approximately 6 weeks given in the morning is superior to placebo in children with ADHD.
Epistemonikos ID: 60f0ae9f18f309b8be819b927154756a488d0e23
First added on: May 04, 2024